The experimental work substantiates the rational use of Celecoxibe and Paracetamol as analgesics to arrest middle intensity pain syndrome at parkinsonism against a background therapy of Bromocriptine. The combination of Bromocriptine with Celecoxibe and Paracetamol usage with the violation of neurosynaptic transmission with clinical displays as catalepsy and tremor promotes development of the pronounced analgetic effect, for certain reduces the displays of Parkinson’s syndrome in an experiment.
